(Q34170324)

31 July 2017

1 reference

title

Long-term care of the liver transplant recipient. (English)

1 reference

31 July 2017

Munoz SJ

1

1 reference

31 July 2017

Rothstein KD

series ordinal

2

1 reference

31 July 2017

Reich D

series ordinal

3

1 reference

31 July 2017

Manzarbeitia C

series ordinal

4

1 reference

31 July 2017

publication date

1 August 2000

1 reference

31 July 2017

published in

Clinics in liver disease

1 reference

31 July 2017

volume

4

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

691-710

1 reference

Modern medical management of obesity: the role of pharmaceutical intervention

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Update in preventive medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Dysarthria and apraxia of speech associated with FK-506 (tacrolimus).

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Influenza vaccination in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506).

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Late hypertension after liver transplantation: a comparison of cyclosporine and tacrolimus (FK 506).

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Medical problems occurring after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Extrapyramidal disorder secondary to cytomegalovirus infection and toxoplasmosis after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Treatment of the postoperative alcoholic liver transplant recipient with other addictions.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Ethanol reduces bone formation and may cause osteoporosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Weight change and obesity after liver transplantation: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome--experience in 300 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Perioperative renal function in patients undergoing orthotopic liver transplantation. A randomized trial of the effects of verapamil.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Neurological complications of liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Neurologic complications of pediatric liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Encephalopathy and neuropathy in end-stage liver disease before and after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

The European Primary Hyperoxaluria Type 1 Transplant Registry report on the results of combined liver/kidney transplantation for primary hyperoxaluria 1984-1994. European PH1 Transplantation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Combined liver-kidney transplantation: what are the indications?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Renal dysfunction associated with liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Renal disease in hepatitis C-positive liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

An economic evaluation of varicella vaccine for pediatric liver and kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Hyperlipidemia in solid organ transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Liver failure in erythropoietic protoporphyria associated with choledocholithiasis and severe post-transplantation polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Drug-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Alendronate Prevents Postmenopausal Bone Loss in Women without Osteoporosis: A Double-Blind, Randomized, Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

The long-term outcome of OKT3 compared with cyclosporine prophylaxis after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Renal insufficiency and hypertension as long-term complications in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Combined liver-kidney transplantation in patients with cirrhosis and renal failure: effect of a positive cross-match and benefits of combined transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Long-term management of the liver transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Calcitriol in prevention and therapy of osteoporosis after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Excessive weight gain after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Relationship of obesity to postoperative complications after cholecystectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Complications following surgery for duodenal ulcer in obese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Encephalopathy in liver transplantation: neuropathology and CMV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Predictive factors of in-hospital CNS complications following liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Hepatoblastoma metastatic to brain: prolonged survival after multiple surgical resections of a solitary brain lesion

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Estrogen-Induced Cholestasis: Clues to Pathogenesis and Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Central Nervous System Lesions in Adult Liver Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Liver transplantation for adult polycystic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

CNS aspergillosis in organ transplantation: a clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Assessment and follow-up of alcohol-dependent liver transplantation patients. A clinical cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Cyclosporine-associated mutism in liver transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Calcitonin and bisphosphonates treatment in bone loss after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Creatinine measurements often yielded false estimates of progression in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Liver transplantation for adult polycystic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Sirolimus: a potent new immunosuppressant for liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

The impact of cyclosporine dose and level on acute rejection and patient and graft survival in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Causes and outcome of seizures in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

Seizures after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970133-1

7 January 2021

10.1016/S1089-3261(05)70133-1

Identifiers

DOI

1 reference

31 July 2017

1 reference